Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall and membrane anionic surface components are essential structural and functional elements that define the surface chemistry of bacteria. In Gram-negative bacteria, the primary anionic component is lipopolysaccharide (LPS), specifically the Lipid A and core oligosaccharide regions (Landman et al., 2008, PMID: 18549350). Gram-positive bacteria utilize teichoic acids, including wall teichoic acid (WTA) and lipoteichoic acid (LTA), as well as anionic phospholipids like phosphatidylglycerol to maintain a negatively charged surface (Swoboda et al., 2010, PMID: 20047350). These components are vital for ion homeostasis, regulation of autolytic enzymes, and protection against host-derived antimicrobial peptides (Heidary et al., 2018, PMID: 30254441). Clinically, these anionic sites serve as the initial binding targets for cationic antibiotics such as polymyxins and daptomycin. Polymyxins bind to the Lipid A of LPS, while daptomycin interacts with phosphatidylglycerol in a calcium-dependent manner, both leading to membrane disruption and cell death (StatPearls, NBK534110). Targeting these components is a key strategy in treating multi-drug resistant bacterial infections, although it carries risks of toxicity due to potential interactions with host membranes at high concentrations. Furthermore, modifications to these anionic components, such as the addition of 4-amino-4-deoxy-L-arabinose to LPS, are primary mechanisms by which bacteria develop resistance to these drugs (Baron et al., 2016, PMID: 27139442).
Drugs typically utilize electrostatic interactions to bind these negatively charged components, leading to membrane permeabilization, depolarization, or inhibition of cell wall biosynthesis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and membrane anionic surface components.